Building tomorrow’s pharmaceutical and biotech enterprise
The pharmaceutical and biotech landscape today is marked by complexity and change, thinning new drug pipelines vs. rising drug discovery costs, patent expirations and generics vs. M&A and externalization, compliance vs. competitiveness, and social media vs. traditional sales. Striking the right balance for success will come from efficient business and cost models, with a healthy dose of innovation, enterprise-wide.
Challenges and opportunities
Greater customer-centricity: Patients now have a higher stake in health management decisions and treatment regimes. They don't want just drugs, they want health solutions. Expectations are rising, more adherence and compliance support for complex and chronic treatments, less cost, and better outcomes.
Shifting sales and marketing paradigms: Changing customer demographics, the Web 2.0 revolution, and the omniscient Internet and mobility are transforming commercial operations, customer interactions, and collaboration. Technology solutions can aid enterprises in making their digital shift seamless and deliver results with a mix of analytics, cross-channel interaction, and customized messaging.
Global regulation and compliance: Enterprises are facing increasing government intervention in healthcare and higher scrutiny of safety, comparative effectiveness, ethics, and quality. Navigating and managing the regulatory and compliance patchwork across the globe is now a business-critical issue, which calls for robust IT frameworks that improve compliance at lower cost.
How Infosys delivers business value
Armed with a diverse blend of industry professionals who understand rapidly shifting industry dynamics, we identify avenues where weaving technology into pharmaceutical and biotech truly pays off. Using our industry-leading strengths in consulting, technology and sourcing, we help clients address their challenges in three ways – business transformation, accelerating innovation, and efficient operations.
Learn more about pharmaceutical and biotech offerings from Infosys